01

Dr. Reddy's Laboratories

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info : RX

Registration Country : USA

METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

Brand Name : SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 500MG;EQ 5MG BASE

Packaging :

Approval Date : 2023-08-09

Application Number : 207678

Regulatory Info : RX

Registration Country : USA

Product Web Link

02

Dr. Reddy's Laboratories

India

DCAT Week

Attending

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info : RX

Registration Country : USA

METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

Brand Name : SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 1GM;EQ 2.5MG BASE

Packaging :

Approval Date : 2023-08-09

Application Number : 207678

Regulatory Info : RX

Registration Country : USA

Product Web Link

03

Dr. Reddy's Laboratories

India

DCAT Week

Attending

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

India

Virtual Booth

Digital Content

Regulatory Info : RX

Registration Country : USA

METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

Brand Name : SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : 1GM;EQ 5MG BASE

Packaging :

Approval Date : 2023-08-09

Application Number : 207678

Regulatory Info : RX

Registration Country : USA

Product Web Link

04

Amneal Pharmaceuticals

U.S.A

NextGen Biomed

Not Confirmed

05

Amneal Pharmaceuticals

U.S.A

NextGen Biomed

Not Confirmed

06

AstraZeneca

United Kingdom

U.S.A

U.S.A

NextGen Biomed

Not Confirmed

Saxagliptin Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

16 API Suppliers

12 USDMF

8 EU WC

5 NDC API

5 Listed Suppliers

$ API Reference Price

INTERMEDIATES

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

41 FDF Dossiers

30 FDA Orange Book

2 Europe

9 Canada

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

1 SPI Pharma

5 DKSH

3 Faran Shimi Pharmaceutical

4 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Aeon Procare

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 BASF

1 Clariant

5 Corel Pharma Chem

6 DFE Pharma

7 Gangwal Chemicals

3 Ideal Cures Pvt Ltd

1 Ingredion Pharma Solutions

26 Kerry

1 Kima Chemical

13 Microlex e.U

1 Novo Excipients

1 Pharmatrans-Sanaq

3 Pluviaendo

3 Prachin Chemical

10 Roquette

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

1 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Fillers, Diluents & Binders

23 Coating Systems & Additives

17 Thickeners and Stabilizers

15 Disintegrants & Superdisintegrants

14 Direct Compression

12 Lubricants & Glidants

11 Granulation

8 Controlled & Modified Release

8 Co-Processed Excipients

7 Rheology Modifiers

6 Film Formers & Plasticizers

3 Taste Masking

3 Solubilizers

3 Topical

3 Emulsifying Agents

3 Parenteral

2 API Stability Enhancers

2 Coloring Agents

2 Chewable & Orodispersible Aids

1 Surfactant & Foaming Agents

DIGITAL CONTENT

12 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 Annual Reports

MARKET PLACE

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 2.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 1GM;EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 500MG;EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 2.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons